TickerTain
TickerTain
NewsroomShortsPortfolioConvergence
NewsroomShortsPortfolioConvergence
←

Arc Institute

private
sign in to save

Arc Institute conducts interdisciplinary biomedical research to accelerate scientific discovery and therapies.

sentiment mix
bull 100%bear 0%neu 0%

funding rounds

private markets
awaiting round data

This slot renders the company's funding history: dates, rounds, amounts, valuations and lead investors once populated in data/funding-rounds.json.

signal summary

latest thesis
Arc Institute releases Evo 2, a genomic foundation model for biology design▾

Arc Institute's Evo 2 model, trained on a trillion DNA bases, represents a major advance in genomic foundation models that can serve as a tool for reasoning models to design biological systems.

jason kellyT2Sequoia Capital2026-03-24
confidence 70 / 100impact Medium
key themes
  • AI Infrastructure100%
  • AI Drug Discovery100%
  • GLP-1 & Metabolic Drugs100%
  • Advanced Manufacturing100%
  • AI Geopolitics & Export Controls100%

bull thesis · 1

88 / 100
  • •Arc Institute releases Evo 2, a genomic foundation model for biology design

bear thesis · 0

—
  • — none —

mentions · 1

Sequoia CapitalHow Autonomous Labs Will Transform Scientific Research: Ginkgo Bioworks’ Jason Kelly1 mentions · 1▲ 0▼ 0○ · 6 months ago
0:002:005:007:0010:00